Nabriva Therapeutics PLC (NASDAQ:NBRV)

0.5841
Delayed Data
As of Sep 18
 -0.0009 / -0.15%
Today’s Change
0.49
Today|||52-Week Range
2.35
-55.75%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$83.7M

Company Description

Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October 2005 and is headquartered in Dublin, Ireland.

Contact Information

Nabriva Therapeutics Plc
25-28 North Wall Quay
Dublin Dublin 1
P:(531) 649-2000
Investor Relations:

Employees

Shareholders

Individual stakeholders9.02%
Mutual fund holders13.14%
Other institutional12.01%

Top Executives

Theodore R. SchroederChief Executive Officer & Director
Steven P. GelonePresident & Chief Operating Officer
Gary L. SenderChief Financial Officer
Jennifer SchranzChief Medical Officer
William Q. SargentVice President-Commercial Strategy & Access